Ludwig Enterprises Company Description
Ludwig Enterprises, Inc. operates as a genomic technology focused on developing testing approaches for inflammation-related chronic diseases, including cancers in the United States.
The company integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits for cancer identification.
It offers mRNA-based screening to provide early insights of potential health risks. The company develops Revealia Breast test, a non-invasive cheek swab screening kit designed to identify and analyze molecular signatures in mRNA expression associated with inflammation-related biological processes associated with the presence of breast cancer.
Ludwig Enterprises, Inc. was founded in 1988 and is based in Miami, Florida.
| Country | United States |
| Founded | 1988 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 5 |
| CEO | Jose Reyes |
Contact Details
Address: 8950 SW 74th Ct Miami, Florida 33156 United States | |
| Phone | 786 363 0166 |
| Website | ludwigent.com |
Stock Details
| Ticker Symbol | LUDG |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US54973P4019 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Jose Antonio Reyes | Interim Chief Executive Officer and President |
| Scott J. Silverman | Chief Financial Officer, Secretary, Treasurer and Director |
| Dr. Marvin S. Hausman M.D. | Chief Science Officer |